CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Income Statement [Abstract]
Revenue	$ 76,000	$ 192,000	$ 76,000	$ 192,000
Cost of revenue	(13,000)	(34,000)	(13,000)	(34,000)
Gross profit	63,000	158,000	63,000	158,000
General and administrative expenses	346,000	172,000	564,000	386,000
Research and development expenses	16,000	0	24,000	36,000
Total operating expenses	362,000	172,000	588,000	422,000
Loss from operations	(299,000)	(14,000)	(525,000)	(264,000)
Other Income (expense)
Gain on patent assignment	880,000	0	880,000	0
Interest expense	(2,000)	(2,000)	(3,000)	(3,000)
Net income (loss)	$ 579,000	$ (16,000)	$ 352,000	$ (267,000)
Net income (loss) per share, Basic	$ 0.00	$ (0.00)	$ 0.00	$ (0.00)
Net income (loss) per share, Diluted	$ 0.00	$ (0.00)	$ 0.00	$ (0.00)
Weighted average shares outstanding, Basic	284,289,740	284,289,740	284,289,740	284,289,740
Weighted average shares outstanding, Diluted	284,289,740	284,289,740	284,289,740	284,289,740